The Himalaya Purifying Neem Face Wash has turned out to be the Drug Company’s money spinner lately as the product has outdone the sales of the firm’s herbal liver medicine, Liv.52. Eventually, the firm has received a significant boost in its presence in the FMCG sector.
As per Philipe Haydon, Himalaya’s CEO, the Purifying Neem FaceWashis currently the market leader as far as the domestic face wash segment is concerned with a market share of around 21 percent. This product has helped the Himalaya Drug Company achieve net sales of Rs 30 crore in the fiscal year 2013 – 2014. On the other hand, the Liv.52 generated net sales of Rs 225 crore in the same time period.
Regarding this the firm’s CEO added that they are bullish that the personal care business will outshine pharma sales by the next fiscal ending March 2016 as they are capable of overtaking the flagship pharma product in terms of sales.
When it comes to the domestic face wash sector,Himalayabattles with Johnson & Johnson (J&J)’s Clean and Clear and Garnier that occupy the second and third slots of this market segment respectively. According to the industry experts, Purifying Neem FaceWashhas become successful owing to the brand equity in the herbal health care segment andHimalaya’s R&D.
As per a senior executive at a rival FMCG firm,Himalayahas managed to be successful in this segment based on its lineage in herbal healthcare. Furthermore, the same is reflected in the advertisements and marketing communications that are made byHimalaya.
In the meantime, in the pharma products segment, Liv.52 is one of the largest selling drugs in the country in November and it also ranks among the top 10 medicine brands inIndiain terms of sales, claim IMS data.
As of now,Himalaya’s pharma and personal care businesses contribute around 38 percent each to the firm’s total revenue estimated to be worth for Rs 1,240 crore. The face wash tallies for 50 percent of the personal care product sales ofHimalaya. The FMCG firm is aiming to receive a total revenue of Rs 1,500 crore this fiscal.